Zobrazeno 1 - 10
of 26
pro vyhledávání: '"ED Litwack"'
Publikováno v:
Ivins, JK; Litwack, ED; Kumbasar, A; Stipp, CS; & Lander, AD. (1997). Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Developmental Biology, 184(2), 320-332. doi: 10.1006/dbio.1997.8532. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4764632z
Cerebroglycan is a glycosylphosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found exclusively in the developing nervous system. In the rodent, cerebroglycan mRNA first appears in regions containing newly generated neurons an
Publikováno v:
Litwack, ED; Stipp, CS; Kumbasar, A; & Lander, AD. (1994). Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 14(6), 3713-3724. doi: 10.1523/jneurosci.14-06-03713.1994. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4vw8z8tm
Cell-surface proteoglycans have been implicated in cell responses to growth factors, extracellular matrix, and cell adhesion molecules. M12, one of the most abundant membrane-associated proteoglycans in the adult rat brain, is a approximately 65 kDa
Publikováno v:
B26. PULMONARY DEVELOPMENTAL BIOLOGY.
Autor:
Horne HN; US Food and Drug Administration, Silver Spring, MD., Roscoe D; US Food and Drug Administration, Silver Spring, MD., Litwack ED; US Food and Drug Administration, Silver Spring, MD., Pathak A; US Food and Drug Administration, Silver Spring, MD., Pandey JP; US Food and Drug Administration, Silver Spring, MD., Gallagher PS; US Food and Drug Administration, Silver Spring, MD., Koontz LM; US Food and Drug Administration, Silver Spring, MD., Schuck RN; US Food and Drug Administration, Silver Spring, MD., Lee EY; US Food and Drug Administration, Silver Spring, MD., Hu YF; US Food and Drug Administration, Silver Spring, MD., Beaver JA; US Food and Drug Administration, Silver Spring, MD., Blumenthal GM; US Food and Drug Administration, Silver Spring, MD., Philip R; US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2019 Mar 19; Vol. 3. Date of Electronic Publication: 2019 Mar 19 (Print Publication: 2019).
Autor:
Schuck RN; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Woodcock J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zineh I; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Stein P; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Jarow J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Temple R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Permutt T; Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., LaVange L; Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Beaver JA; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Charlab R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Blumenthal GM; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Dorff SE; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Leptak C; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Lemery S; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Rogers H; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chowdhury B; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Litwack ED; Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pacanowski M; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Aug; Vol. 104 (2), pp. 282-289. Date of Electronic Publication: 2018 Feb 23.
Autor:
Keating SM; CCS Associates, San Jose, California, USA., Taylor DL; University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Plant AL; Biosystems and Biomaterials Division Materials Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Litwack ED; Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA., Kuhn P; University of Southern California, Los Angeles, California, USA., Greenspan EJ; Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland, USA., Hartshorn CM; National Cancer Institute, Bethesda, Maryland, USA., Sigman CC; CCS Associates, San Jose, California, USA., Kelloff GJ; National Cancer Institute, Bethesda, Maryland, USA., Chang DD; Kite Pharma, Inc., Santa Monica, California, USA., Friberg G; Amgen, Thousand Oaks, California, USA., Lee JSH; Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland, USA., Kuida K; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2018 May; Vol. 11 (3), pp. 267-276. Date of Electronic Publication: 2018 Mar 02.
Autor:
Vicini P; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA., Fields O; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA., Lai E; Takeda Pharmaceuticals International, Deerfield, Illinois, USA., Litwack ED; Food and Drug Administration, Silver Spring, Maryland, USA., Martin AM; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Morgan TM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, and East Hanover, New Jersey, USA., Pacanowski MA; Food and Drug Administration, Silver Spring, Maryland, USA., Papaluca M; European Medicines Agency, London, UK., Perez OD; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA., Ringel MS; Boston Consulting Group, Boston, Massachusetts, USA., Robson M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, and East Hanover, New Jersey, USA., Sakul H; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA., Vockley J; Inova Translational Medicine Institute, Falls Church, Virginia, USA., Zaks T; Sanofi, Cambridge, Massachusetts, USA., Dolsten M; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA., Søgaard M; Pfizer Worldwide Research & Development, La Jolla, California, Collegeville, Pennsylvania, and New York, New York, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2016 Feb; Vol. 99 (2), pp. 198-207. Date of Electronic Publication: 2015 Dec 19.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2015 Jun 04; Vol. 372 (23), pp. 2273-4. Date of Electronic Publication: 2015 May 27.
Autor:
Kilpatrick DL; Department of Microbiology and Physiological Systems, and Program in Neuroscience, University of Massachusetts Medical School, Worcester, MA 01655, USA. Daniel.kilpatrick@umassmed.edu, Wang W, Gronostajski R, Litwack ED
Publikováno v:
Cerebellum (London, England) [Cerebellum] 2012 Mar; Vol. 11 (1), pp. 41-9.
Autor:
Hsu YC; Department of Biochemistry, Developmental Genomics Group, Center of Excellence in Bioinformatics and Life Science, State University of New York at Buffalo, 701 Ellicott St. Buffalo, NY 14203, USA., Osinski J, Campbell CE, Litwack ED, Wang D, Liu S, Bachurski CJ, Gronostajski RM
Publikováno v:
Developmental biology [Dev Biol] 2011 Jun 15; Vol. 354 (2), pp. 242-52. Date of Electronic Publication: 2011 Apr 13.